37452461|t|Impaired aldehyde detoxification exacerbates motor deficits in an alpha-synuclein mouse model of Parkinson's disease.
37452461|a|INTRODUCTION: The discovery of biogenic aldehydes in the postmortem parkinsonian brain and the ability of these aldehydes to modify and cross-link proteins has called attention to their possible role in Parkinson's disease. For example, many in vitro studies have found that the aldehyde metabolite of dopamine, 3,4-dihydroxyphenylacetaldehyde (DOPAL), induces the formation of stable, neurotoxic alpha-synuclein oligomers. METHODS: To study this in vivo, mice deficient in the two aldehyde dehydrogenase enzymes (Aldh1a1 and Aldh2, DKO) primarily responsible for detoxification of DOPAL in the nigrostriatal pathway were crossed with mice that overexpress human wild-type alpha-synuclein. DKO overexpressing human wild-type alpha-synuclein (DKO/ASO) offspring were evaluated for impairment on motor tasks associated with Parkinsonism. RESULTS: DKO/ASO mice developed severe motor deficits greater than that of mice overexpressing human wild-type alpha-synuclein alone. CONCLUSION: These results provide evidence to support the idea that biogenic aldehydes such as DOPAL interact with human wild-type alpha-synuclein, directly or indirectly, in vivo to exacerbate locomotor deficits in Parkinson's disease.
37452461	9	17	aldehyde	Chemical	MESH:D000447
37452461	45	59	motor deficits	Disease	MESH:D009461
37452461	66	81	alpha-synuclein	Gene	20617
37452461	97	116	Parkinson's disease	Disease	MESH:D010300
37452461	158	167	aldehydes	Chemical	MESH:D000447
37452461	186	198	parkinsonian	Disease	MESH:D010300
37452461	230	239	aldehydes	Chemical	MESH:D000447
37452461	321	340	Parkinson's disease	Disease	MESH:D010300
37452461	397	405	aldehyde	Chemical	MESH:D000447
37452461	420	428	dopamine	Chemical	MESH:D004298
37452461	430	461	3,4-dihydroxyphenylacetaldehyde	Chemical	MESH:C007430
37452461	463	468	DOPAL	Chemical	MESH:C007430
37452461	504	514	neurotoxic	Disease	MESH:D020258
37452461	515	530	alpha-synuclein	Gene	6622
37452461	632	639	Aldh1a1	Gene	11668
37452461	644	649	Aldh2	Gene	11669
37452461	651	654	DKO	Chemical	-
37452461	700	705	DOPAL	Chemical	MESH:C007430
37452461	791	806	alpha-synuclein	Gene	6622
37452461	808	811	DKO	Chemical	-
37452461	843	858	alpha-synuclein	Gene	6622
37452461	860	863	DKO	Chemical	-
37452461	912	917	motor	Disease	MESH:D000068079
37452461	940	952	Parkinsonism	Disease	MESH:D010302
37452461	963	966	DKO	Chemical	-
37452461	993	1007	motor deficits	Disease	MESH:D009461
37452461	1065	1080	alpha-synuclein	Gene	6622
37452461	1165	1174	aldehydes	Chemical	MESH:D000447
37452461	1183	1188	DOPAL	Chemical	MESH:C007430
37452461	1219	1234	alpha-synuclein	Gene	6622
37452461	1282	1300	locomotor deficits	Disease	MESH:D001523
37452461	1304	1323	Parkinson's disease	Disease	MESH:D010300
37452461	Association	MESH:C007430	11668
37452461	Association	MESH:D010300	6622
37452461	Association	MESH:C007430	MESH:D010300
37452461	Positive_Correlation	MESH:C007430	6622
37452461	Association	MESH:C007430	11669
37452461	Association	MESH:D000447	6622
37452461	Positive_Correlation	MESH:D000447	MESH:D009461
37452461	Positive_Correlation	MESH:D000447	MESH:D001523
37452461	Positive_Correlation	MESH:C007430	MESH:D001523
37452461	Association	MESH:D001523	6622
37452461	Positive_Correlation	MESH:C007430	MESH:D020258
37452461	Positive_Correlation	MESH:D000447	MESH:D020258
37452461	Association	MESH:D020258	6622
37452461	Association	MESH:D000447	MESH:D010300

